Chemical activators of KIR2.6 can engage various intracellular signaling pathways to modulate the activity of this potassium channel. Phorbol 12-myristate 13-acetate (PMA) directly activates protein kinase C (PKC), which is a key player in phosphorylating target proteins such as KIR2.6, leading to its activation. PKC can also be activated indirectly by other chemical activators. For example, 1-Ethyl-2-benzimidazolinone enhances the activity of cyclic AMP (cAMP), which in turn activates protein kinase A (PKA). PKA then phosphorylates KIR2.6, resulting in its activation. Similarly, Dibucaine inhibits phosphodiesterases, leading to increased levels of cAMP and subsequent activation of PKA, which may activate KIR2.6. Minaprine also increases cAMP levels but does so by activating adenylyl cyclase, setting off a cascade that results in the activation of PKA and subsequent phosphorylation of KIR2.6.
Other chemical activators exert their effects by altering intracellular calcium dynamics. FPL 64176 and Bay K 8644 are calcium channel activators that increase intracellular calcium concentrations, which may activate calcium-dependent potassium channels such as KIR2.6. Zinc Pyrithione and Ciclopirox also elevate intracellular calcium levels, which could activate calcium/calmodulin-dependent protein kinase II (CaMKII), potentially leading to the activation of KIR2.6. NS 1619, a BK channel activator known for increasing calcium sensitivity, can similarly activate KIR2.6 by enhancing its calcium sensitivity. Sevoflurane can potentiate the effect of GABA, leading to membrane hyperpolarization, which in turn could trigger the activation of KIR2.6. Pioglitazone, which acts on PPAR-gamma, may alter the transcription of proteins that regulate potassium channels, thereby influencing the activity of KIR2.6. Finally, Tertiapin-Q, by selectively blocking certain potassium channels, may indirectly cause an upregulation and activation of KIR2.6 as the cell attempts to maintain ionic balance. Each of these chemicals, through their distinct mechanisms, can contribute to the activation of KIR2.6.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC) which is known to phosphorylate a wide range of target proteins, including ion channels like KIR2.6, leading to their activation. | ||||||
1-EBIO | 10045-45-1 | sc-201695 sc-201695A | 10 mg 50 mg | $87.00 $325.00 | 1 | |
1-Ethyl-2-benzimidazolinone enhances the activity of cyclic AMP (cAMP), which can lead to the activation of PKA. PKA then can phosphorylate and activate potassium channels such as KIR2.6. | ||||||
FPL-64176 | 120934-96-5 | sc-201491 | 5 mg | $83.00 | 1 | |
FPL 64176 acts as a calcium channel activator, which can lead to an increased intracellular calcium concentration, indirectly causing the activation of calcium-dependent potassium channels like KIR2.6. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc Pyrithione is known to increase the intracellular calcium concentration, which can activate calcium/calmodulin-dependent protein kinase II (CaMKII), potentially leading to the activation of KIR2.6. | ||||||
Ciclopirox | 29342-05-0 | sc-217893 | 25 mg | $207.00 | 2 | |
Ciclopirox causes an increase in intracellular calcium levels which may activate calcium-dependent pathways, potentially leading to the activation of potassium channels like KIR2.6. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, through its agonist activity on PPAR-gamma, may lead to altered transcription of proteins that regulate potassium channel activity, thus indirectly leading to the activation of KIR2.6. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K 8644 is an L-type calcium channel activator, which may indirectly increase intracellular Ca2+ levels, potentially leading to the activation of Ca2+-sensitive proteins that could activate KIR2.6. | ||||||